Tozaro is reimagining a bioprocessing landscape where downstream processing is simpler and more intuitive. Smart polymers go beyond the limitations of biologics to offer new possibilities in CGT analytics and downstream processing

Providing CFO services to Private Equity backed businesses.

Developing synthetic affinity reagents that offer an alternative approach to detection, capture and purification of challenging target molecules, including Endotoxins, residual PEI, VSV-G and AAV capsids. Unique animal free solutions that can withstand extreme temperatures and caustic environments, and have been exemplified in ELISA, BLI, magnetic resins and chromatography applications.

Advising and managing the fund raising process for the business. Supporting the CEO and Management Team in continuing to develop the business, strategic plans and the delivery of the plan.

Please to announce that I have joined the team at MIP Discovery as maternity cover and to assist in the forthcoming fund raising. This is an exciting time for the business and I am looking forward to bringing all my experience to the business over the coming year.

A dynamic medical device company focused on innovation and new IP and technology development with the aim of Improving patient care and outcomes.

Transition to new CFO following acquisition.

As a Chief Financial Officer & Company Secretary, I lead and develop an international finance team of 20 across 6 countries. I manage business operations, such as finance, insurance, HR, legal, and distributors. I collaborate with Director of Operations to oversee the global business on a daily basis. Involved in expanding business from 10 to 35 Countries. I have improved business performance by restructuring finance department globally through recruitment of new head office team and reorganisation internationally. I have improved efficiency across the business, removed duplication of systems, enhanced visibility of profitability and performance through strategic investment in new business systems. Implemented new auto enrolment pension scheme for UK business. I have overseen a number of legal cases in the UK & Internationally, including patent infringement, product liability, breach of covenant, and unfair dismissal claim.The following are highlights of the value that I bring to the organisation:►Met business needs & objectives by redeveloping financial Processes & reporting system, new transfer pricing models►Developed innovative ideas & business processes that converted loss making business into profitable business unit►Raised £5.5m new equity, at the height of financial crisis►Review acquisition opportunities, managed acquisition process in 2017, valuation, legal & financial due diligence, negotiating price & SPA, managing integration of new acquisition►Amplified business value - leading VDD process, appointing PwC, and developing new business plans, preparation of and involvement in management presentations to potential acquirers►Led all operations of trademark and patent protection►Played an integral role in creating and driving strategy of expansion of the distributor business in Asia and MEA regions that maximised revenue from £300k to £3M►Established & maintained professional relations with banks, auditors, advisors, investors, & key stakeholders

Corporate Financial Controller, I planned innovative working procedures for start-up business and created effective strategies, including fund raising for spin-out of e2v biosensors ltd. I developed and Implemented new corporate risk management procedures and strategies, including FOREX, interest rate and funds management. I oversaw $90M of FX transactions annually. I acted as keen member of strategic bid team to prepare large bids and tenders, including financials and presentations for strategic bids. Displayed exceptional expertise in developing and handling the transfer pricing strategy and documentation for the group in the USA, UK, France, and Germany. I created R&D Tax credit claims. I directed all acquisition operations of MiCS Microchemical Systems SA based in Switzerland for CHF12m. I prepared valuation model, negotiated purchase price and SPA, formulated board papers, financial due diligence, and organised RNS announcement. I spearheaded acquisition of Atmel Grenoble for $140M. I minimised operational costs by negotiating share purchase agreement, bank terms sheets, and £150M facilities agreement.The following were the highlights of the value that I bring to the organisation;►Managed and developed team of 30 across 3 locations►Advised and negotiated acquisition and integration of 6 businesses through career costing from £5m to £100m.►Headed the exit and listing process for E2V Technologies as well as led the MBO process for E2V Technologies. ►Supervised transfer pricing projects as well as oversaw tax risk for the business from £1M to £10M. Negotiated multi-currency £150M bank facility.►Led IFRS / IAS implementation strategy and plan.►Reviewed impact of IFRS 3 - business combinations, IFRS 2 – share based payments, IAS 36 goodwill impairment, and IAS 38 – Intangible assets.►Protected tax position and saved approximately £800K p.a through best financial management strategies

Managing a large team across UK & Europe. Integration of Finance function and financial systems post acquisition by CIBA. Business integration of Italian acquisition and set up. Transfer Pricing. Monthly Reporting. Audit Management. Commercial business support.

Group Management Accountant, responsible for Group Budgeting, Group Management Accounts Consolidation